Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Anti-diarrheal Drugs Market to Gain Sizeable Traction in Asia Pacific

Transparency Market Research
Posted on: 27 Sep 16
Global Anti-diarrheal Drugs Market to Gain Sizeable Traction in Asia Pacific

The global market for anti-diarrheal drugs is the focus of analysis of a recent market intelligence report by Transparency Market Research. The report, titled “Anti Diarrheal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024,” presents an in-depth account of the present state of the market and its crucial elements. With the help of qualitative and quantitative data pertaining to key segments, inputs from industry experts, and a detailed analytical study of the key drivers, restraints, trends, and regulations governing the market, an instructive forecast is developed.

Download free exclusive Brochure of this report:

For the study, the global anti-diarrheal drug market has been segmented based on criteria such as drug class, brand, and geography. The segment of drug class analyzes classes of anti-diarrheal drugs such as non steroidal anti-inflammatory drugs, motility modifying drugs such as opiates and anticholinergics, antimicrobial therapy, anti toxins, anti-mobility agents, and mucosal protectants and adsorbents such as activated charcoal and kaolin-pectin. A detailed overview of over-the-counter drug varieties such as Kaopectate, Imodium A-D, and Pepto-Bismol are also analyzed in the report. Of these, the drug class of anti-mobility agents is the most commonly prescribed and used for treating chronic diarrhea.

On the basis of geography, the market can be segmented into Asia Pacific, North America, Europe, and the Rest of the World. In the U.S., acute diarrhea is one of the most commonly reported diseases. Around the world as well, diarrhea is the second leading causes of death among children aged less than 5 years.

The rate of occurrence of diarrhea is especially higher in developing and under-developed parts of the world owing to lack of clean drinking water and unhygienic sanitation practices. Diarrhea is also known to have a huge impact on the proper development of children and is a leading cause of malnutrition in children. Owing to these factors, the market for anti-diarrheal drugs is expected to witness significant growth in regions such as Asia Pacific and Africa in the next few years.

The report presents a comprehensive overview of the market via in-depth historical data, qualitative insights, and verifiable projections. The report also gives a detailed overview of the regulatory framework guiding and governing the market, and impacting several decisions.

A complete account of the competitive landscape of the global anti-diarrheal drugs market is also given in the report. With the help of a SWOT analysis, the strengths and weaknesses of and the threats and opportunities for the key players in the market are analyzed. Some of the market’s key vendors profiled in the report are Actelion, Glenmark Pharmaceuticals, Lupin, Perrigo, Pfizer, Inc., and GSK.

For more information:

Editor's Details

Ankit jain
Transparency Market Research

Last updated on: 27/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.